State Street Corp Neurocrine Biosciences Inc Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, State Street Corp holds 4,468,266 shares of NBIX stock, worth $576 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
4,468,266
Previous 4,862,116
8.1%
Holding current value
$576 Million
Previous $538 Million
4.44%
% of portfolio
0.02%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding NBIX
# of Institutions
656Shares Held
101MCall Options Held
282KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.83 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.26 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$718 Million0.42% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$398 Million0.04% of portfolio
-
Jpmorgan Chase & CO New York, NY2.67MShares$344 Million0.02% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $12.3B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...